Human clinical-trial data (Phase 1/2 studies in wound healing, cardiac injury, and dry eye) exist only for a different, full-length recombinant thymosin beta-4 product, not for the short synthetic fragment marketed as TB-500, so no completed published human trial has evaluated TB-500 specifically for muscle, tendon, or joint recovery
Some GI adjustment (mild nausea, fullness) is normal and passes within 2-4 weeks
Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society 54 (S6): S3S12
5-Amino-1MQ has shown metabolic benefits in preclinical trials, but no human studies or FDA evaluations currently exist. Hong et al., Nature Medicine Not Typically Screened for in Standard Drug Tests Standard athletic or employment drug tests (urine, hair, blood) do not test for 5-Amino-1MQ
When should I feel better after the injection